Show simple item record

dc.contributor.authorFarkhani, SM
dc.contributor.authorFard, AA
dc.contributor.authorZakeri-Milani, P
dc.contributor.authorMojarrad, JS
dc.contributor.authorValizadeh, H
dc.date.accessioned2018-08-26T07:22:00Z
dc.date.available2018-08-26T07:22:00Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/46208
dc.description.abstractRecently, silver nanoparticles (AgNPs) have been used for cancer treatment. To achieve a successful anti-cancer activity, AgNP needs to be delivered sufficiently to the cells. Cell-penetrating peptides (CPPs) are small cationic peptides that have ability to transport various cargos across cell membranes. In this study, a strategy was developed for cancer treatment, where AgNP modified with CPPs displayed dramatically antitumor activity in MCF-7 cell lines. Peptides-modified AgNPs showed significant enhancement in killing tumor cells by increasing the uptake of AgNP into cell lines and could be a new class of nano-drug for cancer treatment.
dc.language.isoEnglish
dc.relation.ispartofARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
dc.subjectAnticancer
dc.subjectcell-penetrating peptides
dc.subjectcytotoxicity
dc.subjectsilver nanoparticles
dc.titleEnhancing antitumor activity of silver nanoparticles by modification with cell-penetrating peptides
dc.typeArticle
dc.citation.volume45
dc.citation.issue5
dc.citation.spage1029
dc.citation.epage1035
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1080/21691401.2016.1200059


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record